Tarsus Pharmaceuticals (TARS) CEO On First \u0026 Only Demodex Blepharitis Treatment

(7:47)

New Blockbuster in Eyecare! Tarsus Pharmaceuticals TARS Stock | Martin Shkreli

(23:6)

Tarsus Pharmaceuticals - Aziz Mottiwala, Chief Commercial Officer

(6:18)

Martin Shkreli Does Fundamental Research On Tarsus Pharmaceuticals

(1:1:2)

John Hovanesian, MD on Revolutionizing Dry Eye Treatment: Insight from Tarsus Pharmaceuticals

(1:23)

New pill could keep people safe from tick-borne illnesses like Lyme Disease

(1:59)

TARS Stock - Tarsus Pharmaceuticals Inc Stock Breaking News Today | TARS Stock

(2:50)

Tarsus Pharmaceuticals TARS Q3 2024 Earnings Presentation

(46:46)

Tarsus Pharmaceuticals - Aziz Mottiwala, Chief Commercial Officer

(5:37)

Lotilaner Ophthalmic Solution, 0.25% for Demodex Blepharitis: Phase 3 Trial (Saturn-2)

(6:4)

The Disturbing Truth About New Medicines: Are They Really Better? (Pharmaceutical Chemistry)

(17:9)

Lotilaner Ophthalmic Solution, 0.25%, for Treatment of Demodex Blepharitis: Trial Results (Saturn-1)

(7:55)

5 Top Biotech Stocks to Watch in 2024

(6:30)

OIS Podcast Ep #375: What’s New in Ocular Surface Disease

(22:12)

DTx Pharma - FALCON™ (Fatty Acid Ligand Conjugated OligoNucleotide)

(8:31)

Cardinal Health 3PL Services – Warehouse Tour

(3:36)

Pharma Serialization

(4:16)

FDA approval of lotilaner - Xdemvy

(8:)

Inside the OWL Studio - Interview #16 with Alcon

(18:36)

OIS Podcast Ep #372: Commercializing Demedex Blepharitis

(24:28)

Tarsus Pharmaceuticals TARS Q2 2024 Earnings Presentation

(39:59)

75.Medical Maverick : Exploring Pharma Innovation with Dr. Arthur Chan

(36:50)

🔴 Tarsus Pharmaceuticals Inc TARS Stock Information 🔴

(23)

TARS Stock - Tarsus Pharmaceuticals Inc Stock Breaking News Today | TARS Stock Price Prediction

(2:57)

TARS Stock - Tarsus Pharmaceuticals Inc Stock Breaking News Today | TARS Stock Price Prediction

(2:56)

Teaching an Old Drug a New Trick to Prevent Lyme Disease

(20:4)

UPSIDE IS RESUMING : TARS STOCK ANALYSIS | TARSUS PHARMACEUTICALS INC STOCK

(2:8)

Party's over with XDEMVY® (lotilaner ophthalmic solution) 0.25%

(1:1econd)

Roivant Sciences: How we invest and partner with biopharma companies (EN)

(1:24)

Day in the Life: Pfizer Scientist

(51)

Dr. Reddy’s Celevida – The Right Nutrition Partner

(20)

Revolutionary #Tick Repelling Drug Shows Promise in Human Trials #lymedisease

(55)

Dry Eye PipeLine- AR-15512

(1:42)